by Stefan Ravello | Mar 20, 2025 | Hematology-Oncology, Oncology
This curriculum is designed to enhance knowledge, competence, and confidence among oncology clinicians regarding second-line therapy for small cell lung cancer (SCLC). Learners will explore evidence-based treatment sequencing, adverse event management, and emerging...
by Stefan Ravello | Mar 20, 2025 | Allergy and Immunology, Dermatology, Pediatrics, Pulmonology
The Type 2 inflammatory response plays a key role in several conditions, including atopic dermatitis, eosinophilic esophagitis, and asthma. While these diseases may present differently, they share a common underlying pathway, creating opportunities for more targeted...
by Stefan Ravello | Mar 20, 2025 | Hematology-Oncology, Oncology
Endometrial cancer is among the few cancers increasing in incidence and mortality in the United States. In its early stages, endometrial carcinoma has a five-year relative survival rate of 96%, but it decreases to 18% for those with metastases. Surprisingly, mortality...
by mfenimore | Mar 13, 2025 | Oncology, Pulmonology
This curriculum equips healthcare professionals with the knowledge to implement neoadjuvant prehabilitation strategies—such as exercise, nutrition, stress reduction, and smoking cessation—to improve surgical outcomes and quality of life for lung cancer...
by Stefan Ravello | Dec 9, 2024 | Oncology
This curriculum examines the latest advancements in antibody-drug conjugate (ADC) therapy for metastatic triple-negative breast cancer (mTNBC) and HER2-low (HR+/HER2-) breast cancer. It provides insights into mechanisms of action, emerging clinical data, and...
